• Products
        • navify Oncology Hub

          Clinical decision support software designed to enable effective and efficient care decisions across the oncology care continuum.


        • navify Tumor Board

          A cloud-based solution that enhances the efficiency of multidisciplinary tumor board meetings.

        • Apps for navify Tumor Board

          navify Guidelines
          navify Clinical Trial Match
          navify Publication Search
        • navify Mutation Profiler

          A clinical next-generation sequencing reporting solution that can help labs accurately and efficiently interpret the clinical significance of mutations.

        • Apps for navify Mutation Profiler

          navify Therapy Matcher
          navify Clinical Trial Matcher

        • navify Mutation Caller

          A cloud-based next-generation sequencing secondary analysis solution that efficiently and accurately identifies variants for Roche reagents.

        • navify Digital Pathology

          A universal platform to manage cases and view, organize, retrieve and integrate digital tissue images.


        • navify Pass

          A seamless, secure way to track, manage and share important healthcare test results.


        • navify Sample Tracking

          Our navify Sample Tracking solution provides you with the operational insights to optimize your pre-pre-analytic operations.

  • Why navify
        • For healthcare leaders

          Optimizing clinical decision-making

          Managing the data avalanche
          Rethinking multidisciplinary collaboration
          Streamlining tumor board preparation
          Supporting guidelines compliance
        • For lab leaders

          Building an intelligent lab

          Differentiate from competitors & impact patient care
          Improving the operational efficiency of your lab
          Integrate data streams
        • For clinicians

          Improving patients’ experience

          Reducing time to treatment
          Improving clinical care coordination
          Increasing patient engagement
        • For IT leaders

          Innovating healthcare IT

          Open, interoperable ecosystem
          Security & privacy
          Integration & implementation
  • Clinical evidence
  • Stories
        • Clinician stories

          As physicians and their clinical staff prioritize remote care management, proactive assessment of cancer patients is critical. Despite difficult circumstances, clinicians continue to pursue innovative ways of providing personalized cancer care.


        • MITO Cooperative, Italy

          How a molecular tumor board cooperative improved collaboration among its members and timely data review to increase clinical trial enrollment.

        • Hospital del Mar, Barcelona, Spain

          Homegrown solutions made tumor board processes time consuming and cumbersome. The hospital needed a streamlined, faster approach. Hospital del Mar implemented navify Tumor Board for its breast cancer tumor boards.


        • Institut für Hämatopathologie Hamburg (HpH Hamburg), Germany

          navify Tumor Board enables secure and efficient collaboration.

        • Ellis Fischel Cancer Center University of Missouri (MU)

          Ten subspecialty tumor boards relied on legacy technologies and data from diverse sources, manually searched and added to PowerPoint presentations. MU needed an updated, better process.


        • Galway University Hospitals

          A critical national cyber security event and the effectiveness of compensating technical controls provided by Roche managed firewalls

  • About us
        • Roche heritage

          Roche is an Industrial Age entrepreneur, an innovator in cancer care and biomedical research and a leader in in vitro diagnostics — building toward its vision of personalized healthcare.

        • Vision & mission

          We endeavor to drive toward a better future for patients by offering data-focused, patient-centric and value-based personalized healthcare.

        • News & events

          Find the latest news and events related to navify portfolio. Read all about the latest collaborations, tools and research that help improve personalized care.

  • Products
        • Back

          Go to Products overview

        • navify Oncology Hub

        • navify Tumor Board

          Apps for navify Tumor Board

        • navify Mutation Caller

        • navify Mutation Profiler

          Apps for navify Mutation Profiler

        • navify Digital Pathology

        • navify Pass

        • navify Sample Tracking

  • Why navify
        • Back

          Go to Why navify

          Back to “Why navify”

          Go to Improving patients’ experience overview

          Go to optimizing clinical decision-making overview

          Go to Innovating healthcare IT overview

          Go to Building an intelligent lab overview

        • Improving patients’ experience

        • Optimizing clinical decision-making

        • Innovating healthcare IT

        • Building an intelligent lab

        • Reducing time to treatment

          Improving clinical care coordination

          Increasing patient engagement

          Managing the data avalanche

          Rethinking multidisciplinary collaboration

          Streamlining tumor board preparation

          Supporting guidelines compliance

          Open, interoperable ecosystem

          Security & privacy

          Integration & implementation

          Improving quality of care through systems & data

          Simplifying KPI tracking & reporting

          Operationalizing value-based care

          Differentiate from competitors & impact patient care

          Improving the operational efficiency of your lab

          Integrate data streams

  • Clinical evidence
  • Stories
        • Back

          Go to Stories overview

        • Clinician stories

          As physicians and their clinical staff prioritize remote care management, proactive assessment of cancer patients is critical. Despite difficult circumstances, clinicians continue to pursue innovative ways of providing personalized cancer care.

        • Hospital del Mar, Barcelona, Spain

          Homegrown solutions made tumor board processes time consuming and cumbersome. The hospital needed a streamlined, faster approach. Hospital del Mar implemented navify Tumor Board for its breast cancer tumor boards.

        • Ellis Fischel Cancer Center University of Missouri (MU)

          Ten subspecialty tumor boards relied on legacy technologies and data from diverse sources, manually searched and added to PowerPoint presentations. MU needed an updated, better process.

        • Institut für Hämatopathologie Hamburg (HpH Hamburg), Germany

          navify Tumor Board enables secure and efficient collaboration.

        • Galway University Hospitals

          A critical national cyber security event and the effectiveness of compensating technical controls provided by Roche managed firewalls

  • About Us
        • Back

          Go to About Us overview

        • Roche heritage

          Vision & mission

          News & events

           

  • Menu Menu

Right Header Area

Request a demoSearch

Roche launches navify Oncology Hub to simplify clinical workflows and empower timely, personalised decisions across the oncology care continuum

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of navify Oncology Hub, its latest digital solution to further enhance clinical decision support and workflow optimisation for oncologists and oncology care teams.

Oncologists often face incomplete patient records and data silos across multiple IT systems. This makes it difficult to find and collect all relevant data to get the full picture of the patient’s health history and assess each case holistically. These workflow inefficiencies can also create significant administrative, operational and financial burden.

navify Oncology Hub addresses these challenges by securely aggregating and organising fragmented patient data across an institution’s IT systems. It simplifies day-to-day workflows for oncology care teams and serves as a central workspace where the most relevant patient data can easily be found, accessed and reviewed by all members of the team. navify Oncology Hub presents the information as a longitudinal timeline view of the patient’s full oncologic history, combined with a concise snapshot of the individual’s current status. With it, clinicians can efficiently prepare for patient consultations, quickly and concisely convey information and coordinate care across the team. navify Oncology Hub also helps facilitate discussions between oncologists and patients about complex treatment options and next steps.

“Clinicians are under enormous pressure to navigate complex workflows and consider all the relevant information to decide on the best possible care option for each patient in a timely fashion,”

says Moritz Hartmann, Global Head of Roche Information Solutions. 

“With our digital solutions, we can empower healthcare professionals and patients to make personalised, insights-based decisions across the patient care continuum – helping improve outcomes, and reduce costs to society.”

navify Oncology Hub, the latest addition to the navify Decision Support portfolio, will be initially available in the US, Germany and Taiwan before being rolled out to additional markets in the near future.

About navify Decision Support portfolio

navify Decision Support portfolio is a portfolio of interoperable, scalable workflow products and clinical decision support solutions that empower personalized healthcare. By aggregating patient-specific information with relevant, curated scientific and medical data from an ever-expanding knowledge base, clinicians can confidently make more personalized, timely decisions – fundamentally changing the way diseases are managed across the care continuum. For more information, please visit www.navify.com/products

About Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics, as well as growing capabilities in the area of data-driven medical insights help Roche deliver truly personalised healthcare. Roche is working with partners across the healthcare sector to provide the best care for each person.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. In recent years, Roche has invested in genomic profiling and real-world data partnerships and has become an industry-leading partner for medical insights.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the twelfth consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2020 employed more than 100,000 people worldwide. In 2020, Roche invested CHF 12.2 billion in R&D and posted sales of CHF 58.3 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan. For more information, please visit www.roche.com.

Categories

  • All
  • Events
  • News

Archives

Interested in learning more?

Request a demo

  • Improving patients’ experience
  • Reducing time to treatment
  • Improving clinical care coordination
  • Increasing patient engagement
  • Optimizing clinical decision-making
  • Managing the data avalanche
  • Rethinking multidisciplinary collaboration
  • Streamlining tumor board preparation
  • Supporting guidelines compliance
  • Building an intelligent lab
  • Differentiate from competitors & impact patient care
  • Improving the operational efficiency of your lab
  • Integrate data streams

Find us
Roche Information Solutions
Roche Molecular Systems, Inc.
2881 Scott Blvd
Santa Clara, CA 95050












  • Innovating healthcare IT
  • Open, interoperable ecosystem
  • Security & privacy
  • Integration & implementation
  • About us
  • Roche heritage
  • Vision & mission
  • News & events
  • Stories
  • Clinical evidence
  • Products
  • navify Oncology Hub
  • navify Tumor Board
  • navify Mutation Profiler
  • navify Mutation Caller
  • navify Digital Pathology
  • navify Pass
  • navify Sample Tracking

© 2023 Roche Molecular Systems, Inc.
NAVIFY is a trademark of Roche.
All other product names and trademarks are the property of their respective owners.

  • Terms & conditions
  • Privacy policy
  • Cookie policy
  • Cookie preferences
  • California supplemental privacy notice

Not all products of this product portfolio are intended or approved for diagnostic use. This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any valid legal process, regulation, registration or usage in the country of your origin.

Roche at HIMSS Europe 2022: Delivering the future of healthcare
Scroll to top
×

You will be redirected to another site. Do you want to continue?

OK